浏览全部资源
扫码关注微信
首都医科大学附属北京地坛医院中西医结合二科,北京 100015
陈新征,女,45岁,大学本科,副主任护师。研究方向:慢性肝病的中西医结合护理。
周洋,E-mail:zy017d@126.com
收稿日期:2024-04-29,
纸质出版日期:2025-03-25
移动端阅览
陈新征,侯艺鑫,孟培培,等.逐水消胀方脐敷治疗肝硬化腹水的疗效观察[J].北京中医药,2025,44(3):296-300.
CHEN Xinzheng,HOU Yixin,MENG Peipei,et al.Clinical efficacy of Zhushui Xiaozhang Formula in treatment of ascites due to hepatic cirrhosis via umbilical compress[J]. Beijing Journal of Traditional Chinese Medicine,2025,44(03):296-300.
陈新征,侯艺鑫,孟培培,等.逐水消胀方脐敷治疗肝硬化腹水的疗效观察[J].北京中医药,2025,44(3):296-300. DOI: 10.16025/j.1674-1307.2025.03.007.
CHEN Xinzheng,HOU Yixin,MENG Peipei,et al.Clinical efficacy of Zhushui Xiaozhang Formula in treatment of ascites due to hepatic cirrhosis via umbilical compress[J]. Beijing Journal of Traditional Chinese Medicine,2025,44(03):296-300. DOI: 10.16025/j.1674-1307.2025.03.007.
目的
2
观察逐水消胀方脐敷对肝硬化腹水患者的疗效。
方法
2
选取2021年6月1日—12月31日首都医科大学附属北京地坛医院中西医结合中心收治的肝硬化腹水患者70例,采用随机数字表法分为观察组与对照组,各35例。对照组给予规范的基础治疗,观察组给予基础治疗+逐水消胀方脐敷,疗程均为2周。分别于治疗前及治疗1、2周,对比2组中医主要症状积分、腹水深度、腹围、空腹体质量。监测2组不良反应发生情况。
结果
2
治疗1、2周后,2组患者腹胀、纳差、双下肢水肿、乏力积分均较治疗前下降(
P
<
0.05);治疗1周后观察组腹胀、纳差、双下肢水肿积分均低于对照组(
P
<
0.05),治疗2周后观察组腹胀、纳差、双下肢水肿、乏力积分均低于对照组(
P
<
0.05)。治疗1、2周后,2组腹水深度、腹围及体质量均较治疗前下降(
P
<
0.05),观察组腹水深度及腹围均低于对照组(
P
<
0.05)。治疗过程中,观察组有1例患者治疗初期出现脐周局部皮肤潮红,无糜烂、渗出、皮疹、瘙痒等,继续使用未见症状加重。
结论
2
逐水消胀方脐敷可明显改善肝硬化腹水患者临床症状,且安全性高。
Objective
2
To observe the efficacy of
Zhushui Xiaozhang Formula
in treatment of ascites in patients due to hepatic cirrhosis via umbilical compress.
Methods
2
Seventy patients with hepatic cirrhosis-induced ascites, who were admitted to the Integrated Traditional Chinese and Western Medicine Center of Beijing Ditan Hospital, Capital Medical University, from June 1 to December 31, 2021, were enrolled and randomly divided into an observation group and a control group according to a random number table, with 35 patients in each group. The control group received standard basic treatment, while the observation group received basic treatment combined with
Zhushui Xiaozhang Formula
via umbilical compress. The treatment duration was 2 weeks. The two groups were compared before treatment and at the 1st and 2nd week of treatment in terms of major traditional Chinese medicine (TCM) symptom scores, ascites depth, abdominal circumference, and fasting body weight. The occurrence of adverse reactions was also monitored.
Results
2
After 1 and 2 weeks of treatment, the scores for abdominal distension, poor appetite, lower limb edema, and fatigue in both groups decreased significantly compared to pre-treatment levels (
P
<
0.05). After 1 week of treatment, the observation group had lower scores for abdominal distension, poor appetite, and lower limb edema compared to the control group (
P
<
0.05). After 2 weeks of treatment, the observation group had lower scores for abdominal distension, poor appetite, lower limb edema, and fatigue compared to the control group (
P
<
0.05). After 1 and 2 weeks of treatment, both groups showed a decrease in ascites depth, abdominal circumference, and body weight compared to pre-treatment levels (
P
<
0.05). The observation group had significantly lower ascites depth and abdominal circumference compared to the control group (
P
<
0.05). During treatment, one patient in the observation group developed slight redness around the umbilical area at the beginning of treatment, but there was no erosion, exudation, rash, or itching. The symptoms did not worsen after continued treatment.
Conclusion
2
Zhushui Xiaozhang Formula
via umbilical compress can significantly improve the clinical symptoms of patients with hepatic cirrhosis-induced ascites, with a high safety profile.
梁扩寰 , 李绍白 . 肝脏病学 [M ] . 北京 : 人民卫生出版社 , 2003 : 836 .
PLANAS R , MONTOLIU S , BALLESTÉ B , et al . Natural history of patients hospitalized for management of cirrhotic ascites [J ] . Clin Gastroenterol Hepatol , 2006 , 4 ( 11 ): 1385 - 1394 .
KRAG A , BENDTSEN F , HENRIKSEN JH , et al . Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites [J ] . Gut , 2010 , 59 ( 1 ): 105 - 110 .
中华中医药学会脾胃病分会 . 肝硬化腹水中医诊疗专家共识(2023) [J ] . 临床肝胆病杂志 , 2023 , 39 ( 12 ): 2775 - 2781 .
中华医学会肝病学分会 . 肝硬化腹水诊治指南(2023) [J ] . 中华肝脏病杂志 , 2023 , 31 ( 8 ): 813 - 826 .
BIGGINS SW , ANGELI P , GARCIA-TSAO G , et al . Diagno⁃sis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 prac⁃tice guidance by the American association for the study of liver diseases [J ] . Hepatology , 2021 , 74 ( 2 ): 1014 - 1048 .
石俊豪 , 赵晨露 , 李亚东 , 等 . 中药穴位贴敷治疗肝硬化腹水研究进展 [J ] . 中医学报 , 2023 , 38 ( 7 ): 1459 - 1467 .
俞媛 , 张建良 , 陆云飞 , 等 . 中医外治法在肝硬化腹水中的应用进展 [J ] . 临床肝胆病杂志 , 2016 , 32 ( 4 ): 781 - 784 .
中华医学会肝病学分会 . 肝硬化腹水及相关并发症的诊疗指南 [J ] . 临床肝胆病杂志 , 2017 , 33 ( 10 ): 1847 - 1863 .
郑筱萸 . 中药新药临床研究指导原则(试行) [M ] . 北京 : 中国医药科技出版 , 2002 : 29 - 31 .
李杰 , 徐春军 . 黄芪、牵牛子、防己配伍治疗肝硬化腹水用药心得 [J ] . 中医杂志 2014 , 55 ( 2 ): 164 - 165 .
陈虹秀 , 吴雨泉 , 刘光伟 . 脐透利水贴辅助治疗肝硬化难治性腹水血瘀水停证患者36例临床观察 [J ] . 中医杂志 , 2023 , 64 ( 14 ): 1462 - 1468 .
黄清华 , 黄凯舟 , 蒋开平 , 等 . 逐水消胀散脐敷治疗肝硬化顽固性腹水临床研究 [J ] . 光明中医 , 2021 , 36 ( 15 ): 2531 - 2533 .
李婷 , 徐春军 , 李尚点 , 等 . 脐疗辅助治疗肝硬化腹水的Meta分析 [J ] . 中西医结合肝病杂志 , 2019 , 29 ( 6 ): 533 - 538 .
中华中医药学会脾胃病分会 . 肝硬化腹水中医诊疗规范专家共识意见 [J ] . 北京中医药 , 2012 , 31 ( 11 ): 868 - 872 .
代倩兰 , 江锋 , 王京 , 等 . 基于中医传承辅助系统的肝硬化腹水敷脐用药规律分析 [J ] . 中国中药杂志 , 2018 , 43 ( 22 ): 4541 - 4546 .
申俊丽 , 董鑫 , 孙宏新 . 甘遂的临床运用 [J ] . 中医研究 , 2019 , 32 ( 7 ): 62 - 65 .
杨莉萍 , 郭旭东 , 席少阳 , 等 . 经典名方中牵牛子的本草考证 [J ] . 中国实验方剂学杂志 , 2024 , 30 ( 6 ): 179 - 189 .
闫子民 , 齐文升 . 峻下逐水法治疗恶性胸腔积液1则 [J ] . 北京中医药 , 2023 , 42 ( 1 ): 122 - 124 .
谢露 , 陈虹秀 , 郝君玉 , 等 . 软肝利水方联合逐水方敷脐治疗脾虚水停型肝硬化难治性腹水的临床研究 [J ] . 中西医结合肝病杂志 , 2023 , 33 ( 3 ): 220 - 223 .
马丽 , 孟宪华 , 杨军丽 . 甘遂化学成分、药理活性和临床应用研究进展 [J ] . 天然产物研究与开发 , 2022 , 34 ( 4 ): 699 - 712 .
向玉林 , 罗征 , 孙媛 , 等 . 牵牛子化学成分及其生物活性研究进展 [J ] . 中华中医药学刊 , 2022 , 40 ( 6 ): 114 - 122 .
李英奇 , 曾彦杰 , 曾健青 , 等 . 脱脂肉桂粉提取肉桂多酚的研究 [J ] . 中草药 , 2017 , 48 ( 21 ): 4448 - 4452 .
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构